Citizens, INC

Market Movers (8-K)

NYSE
Citizens, Inc. announced the results of its 2026 Annual Meeting of Shareholders, with overwhelming support for director nominees, auditor ratification, executive compensation, and an incentive plan.
NYSE
Citizens, Inc. announced a significant turnaround in its first quarter 2026 results, reporting a net income of $2.3 million compared to a loss in the prior year, driven by revenue growth and improved operational efficiencies.
Better than expected
NYSE
Citizens, Inc. announced record full year and fourth quarter 2025 revenues, alongside significant growth in insurance in force and agent network.
Better than expected
NYSE
Citizens, Inc. announced its third quarter 2025 financial results, showcasing growth in agents and insurance in force, alongside the appointment of Michael Harwood to its Board of Directors.
NYSE
Citizens, Inc. announced robust second quarter 2025 financial results, driven by record insurance in force and significant agent network expansion.
Better than expected
NYSE
Citizens, Inc. announced the successful outcomes of its 2025 Annual Meeting of Shareholders, where all eight director nominees were elected, Grant Thornton LLP was ratified as independent auditor, and executive compensation received advisory approval.

Quarterly Earnings (10-Q)

NYSE
Citizens, Inc. reported a mixed third quarter, with increased revenues and net investment income, but a decline in year-to-date net income driven by investment losses and higher matured endowment payouts.
Capital raise
Worse than expected
NYSE
Citizens, Inc. reported a significant increase in Q2 net income before tax, driven by premium growth and lower expenses, but saw a year-to-date profit decline due to an investment write-down and anticipated endowment maturities.
Capital raise
NYSE
Citizens, Inc.'s first quarter 2025 results were impacted by investment-related losses, particularly a write-down of a BlackRock ESG investment, leading to a net loss.
Worse than expected
NYSE
Citizens Inc. experienced a decrease in net income before taxes in Q3 2024, despite revenue growth, due to increased expenses and reserve adjustments.
Worse than expected
Capital raise
NYSE
Citizens, Inc. experienced a decrease in net income for the second quarter of 2024, impacted by legal fees and increased benefit payments, despite revenue growth.
Worse than expected
NYSE
Citizens, Inc. saw a slight decrease in net income for the first quarter of 2024, despite increased premium revenue and investment gains.
Worse than expected
Capital raise

Annual Reports (10-K)

NYSE
Citizens, Inc. announced a second consecutive year of total premium revenue growth in 2025, driven by domestic insurance sales and strategic initiatives, despite increased international endowment maturities.
Capital raise
Better than expected
NYSE
Citizens, Inc. announces a significant increase in new insurance issued and a return to premium revenue growth, alongside a decrease in net income due to legal fees and investment losses.
Worse than expected
NYSE
Citizens, Inc. reports a net income of $24.4 million for 2023, driven by strategic initiatives and international business growth, despite challenges from market volatility and rising interest rates.
Worse than expected
Capital raise

Insider Trading (Form 4)

NYSE
Bryon Matthew Lewis, Chief Operations Officer of Citizens, Inc., reported a transaction in 10,697 shares of common stock on July 14, 2026.
NYSE
Director Jerry Davis acquired 1,820 shares of Citizens, Inc. Class A Common Stock through a recurring stock investment plan.
NYSE
Jon Stenberg, President & CEO and Director of CITIZENS, INC. (CIA), acquired 10,000 shares of Class A Common Stock.
NYSE
Director Cynthia H. Davis acquired additional shares of Citizens, Inc. (CIA) through open market purchases and dividend reinvestments.
NYSE
CEO Jon Stenberg acquired 13,186 shares of Citizens, Inc. through the vesting of restricted stock units and withheld 3,211 shares for tax obligations.
NYSE
CFO Jeffery P. Conklin reported the vesting of restricted stock units and a new equity grant in a Form 4 filing.

Proxy Statements (Def-14A)

NYSE
Citizens, Inc. has announced its 2026 Annual Meeting of Shareholders, set for June 16, 2026, to elect directors, ratify auditor appointment, approve executive compensation, and vote on an amended incentive plan.
NYSE
Citizens, Inc. has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.
NYSE
Citizens, Inc. is set to hold its 2025 Annual Meeting of Shareholders on June 17, 2025, to elect directors, ratify the appointment of Grant Thornton LLP, and conduct an advisory vote on executive compensation.
Worse than expected
NYSE
Citizens, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NYSE
Citizens, Inc. invites shareholders to its 2024 Annual Meeting, highlighting growth driven by new products, distribution channels, and strategic initiatives.
Worse than expected

Schedule 13G - Passive Investments

NYSE
Continental General Insurance Co and affiliated entities, including Michael Gorzynski, have reported a 5.0% beneficial ownership stake in Citizens, Inc.'s Class A Common Stock.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a passive beneficial ownership of 5.8% of Citizens, Inc.'s Class A Stock.